Drug Report History #270089

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2026-03-25 2026-03-25
Drug Identification Number 02244849 02244849
Brand name COLISTIMETHATE FOR INJECTION U.S.P. COLISTIMETHATE FOR INJECTION U.S.P.
Common or Proper name COLISTIMETHATE FOR INJECTION U.S.PS COLISTIMETHATE FOR INJECTION U.S.PS
Company Name STERIMAX INC STERIMAX INC
Ingredients COLISTIN COLISTIN
Strength(s) 150MG 150MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 1 VIAL 1 VIAL
Additional packaging sizes
ATC code J01XB J01XB
ATC description OTHER ANTIBACTERIALS OTHER ANTIBACTERIALS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2026-02-28 2026-02-28
Actual discontinuation date 2026-02-28 2026-02-28
Remaining supply date 2026-02-28 2026-02-28
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments